Dorsey & Whitney Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.76M Buy
10,676
+367
+4% +$131K 0.21% 110
2025
Q4
$3.37M Buy
10,309
+37
+0.4% +$11.7K 0.18% 122
2025
Q3
$2.9M Sell
10,272
-9,826
-49% -$2.85M 0.15% 129
2025
Q2
$5.61M Buy
20,098
+75
+0.4% +$21.2K 0.3% 78
2025
Q1
$6.24M Buy
20,023
+891
+5% +$263K 0.36% 62
2024
Q4
$4.99M Buy
19,132
+327
+2% +$97K 0.27% 84
2024
Q3
$6.06M Buy
18,805
+10,459
+125% +$3.42M 0.32% 65
2024
Q2
$2.61M Sell
8,346
-219
-3% -$64.3K 0.18% 112
2024
Q1
$2.44M Buy
8,565
+490
+6% +$143K 0.17% 116
2023
Q4
$2.33M Sell
8,075
-160
-2% -$43.6K 0.18% 122
2023
Q3
$2.21M Buy
8,235
+265
+3% +$66.1K 0.19% 121
2023
Q2
$1.77M Buy
7,970
+1,054
+15% +$245K 0.15% 136
2023
Q1
$1.67M Buy
6,916
+196
+3% +$48.1K 0.15% 139
2022
Q4
$1.76M Buy
6,720
+127
+2% +$34K 0.17% 127
2022
Q3
$1.49M Sell
6,593
-213
-3% -$51.6K 0.16% 136
2022
Q2
$1.66M Buy
6,806
+536
+9% +$131K 0.17% 127
2022
Q1
$1.52M Buy
6,270
+70
+1% +$16.1K 0.13% 149
2021
Q4
$1.4M Buy
6,200
+592
+11% +$125K 0.12% 164
2021
Q3
$1.2M Sell
5,608
-99
-2% -$22.8K 0.11% 166
2021
Q2
$1.39M Sell
5,707
-869
-13% -$214K 0.13% 150
2021
Q1
$1.64M Sell
6,576
-427
-6% -$102K 0.16% 134
2020
Q4
$1.54M Buy
7,003
+45
+0.6% +$10.4K 0.18% 120
2020
Q3
$1.77M Buy
6,958
+46
+0.7% +$11.4K 0.24% 104
2020
Q2
$1.63M Buy
6,912
+58
+0.8% +$13.2K 0.23% 108
2020
Q1
$1.39M Sell
6,854
-73
-1% -$15.9K 0.23% 107
2019
Q4
$1.67M Buy
6,927
+295
+4% +$65K 0.22% 109
2019
Q3
$1.28M Buy
6,632
+1,252
+23% +$240K 0.19% 119
2019
Q2
$990K Buy
5,380
+256
+5% +$45.8K 0.15% 130
2019
Q1
$975K Sell
5,124
-1,046
-17% -$200K 0.15% 130
2018
Q4
$1.2M Buy
6,170
+298
+5% +$58.1K 0.21% 107
2018
Q3
$1.22M Buy
5,872
+663
+13% +$131K 0.19% 112
2018
Q2
$961K Buy
5,209
+310
+6% +$54.8K 0.17% 122
2018
Q1
$834K Sell
4,899
-541
-10% -$99.3K 0.15% 121
2017
Q4
$946K Sell
5,440
-74
-1% -$13.1K 0.17% 105
2017
Q3
$1.03M Buy
5,514
+157
+3% +$27.8K 0.2% 98
2017
Q2
$923K Buy
5,357
+51
+1% +$8.29K 0.18% 104
2017
Q1
$870K Buy
5,306
+437
+9% +$72.6K 0.18% 105
2016
Q4
$713K Sell
4,869
-426
-8% -$64.1K 0.16% 106
2016
Q3
$884K Sell
5,295
-224
-4% -$37.9K 0.2% 101
2016
Q2
$839K Sell
5,519
-47
-0.8% -$7.31K 0.19% 98
2016
Q1
$833K Buy
5,566
+274
+5% +$40.7K 0.21% 97
2015
Q4
$858K Sell
5,292
-380
-7% -$59.7K 0.23% 92
2015
Q3
$783K Buy
5,672
+401
+8% +$63.2K 0.22% 91
2015
Q2
$809K Buy
5,271
+85
+2% +$13.6K 0.21% 92
2015
Q1
$829K Buy
5,186
+102
+2% +$16.1K 0.21% 93
2014
Q4
$811K Buy
5,084
+74
+1% +$11.5K 0.21% 91
2014
Q3
$705K Sell
5,010
-394
-7% -$51.4K 0.19% 100
2014
Q2
$641K Buy
5,404
+340
+7% +$39.4K 0.14% 106
2014
Q1
$625K Buy
5,064
+175
+4% +$21.2K 0.14% 105
2013
Q4
$558K Buy
4,889
+15
+0.3% +$1.71K 0.15% 118
2013
Q3
$547K Buy
4,874
+1,082
+29% +$117K 0.16% 109
2013
Q2
$374K Buy
+3,792
New +$394K 0.12% 140

Other funds holding AMGN

Dorsey & Whitney Trust's AMGN Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Amgen (AMGN) stake by 3.6% in Q1 2026, buying an estimated $131K and bringing the position to 10,676 shares worth $3.76M. The position accounts for 0.21% of the portfolio, ranked #110.

Dorsey & Whitney Trust first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.24M in Q1 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Dorsey & Whitney Trust held 10,676 shares of Amgen worth $3.76M as of Q1 2026.
  • Dorsey & Whitney Trust bought 367 Amgen shares in Q1 2026, an estimated $131K.
  • Amgen made up 0.21% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #110 holding.
  • Dorsey & Whitney Trust first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Dorsey & Whitney Trust's Amgen position peaked at $6.24M in Q1 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.